Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 5, 2021Blood

Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

AZAmer M. ZeidanYale Cancer CenterUBUma BorateThe Ohio State UniversityDPDaniel A. PollyeaUniversity of Colorado Anschutz Medical Campus

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeidan et al. (2021) studied this question.

synapsesocial.com/papers/6a11c1bfe2cb0ccec0c906dfhttps://doi.org/10.1182/blood-2021-145646
View Full Paper
Ask AI
Bookmark
Share